{"nct_id":"NCT04639986","title":"Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2020-11-23","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2025-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GILD"]}